STAREE

STAREE 'Statins in Reducing Events in the Elderly' is recruiting people for a clinical trial investigating the effects of statins for the prevention of dementia, heart attacks, strokes and the need for long term residential care in people aged 70, and above.

Information accompanying the clinical trial goes on to say that "statins are currently prescribed to prevent heart attacks and strokes in people who have had one in the past however, doctors are unsure if statins should be prescribed to prevent healthy people from developing those diseases in the first place.


Research is apparently being led by Monash. Uni in collaboration with Curtin Uni and the University of Tasmania, funded by the National Health and Medical Research Council!
The role of statins in healthy people over 70 is questionable. Who would want to be a part of this trial?


Quote:

"The man in my consulting room was in his mid-50s and had arrived complaining of severe chest pain. ‘I’ve had it for a while now, doctor,’ he said, grimacing, ‘it won’t go away.’
I glanced at his notes — an angiogram had showed that his heart was fine, while an endoscopy had revealed there was nothing untoward going on in his oesophagus or stomach. Then I asked what drugs he was taking regularly. ‘Well, nothing really?.?.?. just statins.’
That was almost certainly the culprit. I asked him to stop taking them for a fortnight, which, despite protests from his GP, he did and, lo and behold, two weeks later the patient was pain-free.
I recommended he embrace the so-called Mediterranean diet and exercise a little more, and he went away a happy and healthy middle-aged man.
If NICE (the National Institute for Clinical Excellence) gets its way, that scenario could be needlessly played out in GP surgeries and hospital consulting rooms hundreds of thousands of times a year. It would mean 12 million of us taking a little pill before bed, five million more than take statins today.
That’s five million more patients for the NHS to keep an eye on, five million more people who, despite the fact many will be in good health, have been well and truly ‘medicalised’ and face the prospect of spending the rest of their lives on daily medication.
In making its recommendation, NICE seems to be siding firmly with the drug companies and relying on industry- sponsored statistics which consistently under-report — some would even say hide — the risk of side-effects.
These statistics will tell you that perhaps one in 10,000 patients taking statins will suffer severe muscular pain as a side-effect.
In contrast, reliable data from the real world, published recently in the British Medical Journal and backed up by anecdotal evidence from my experience as a cardiac physician, suggests that the real figure for serious side-effects associated with statin use is closer to one in five.
In other words, if NICE succeeds in turning five million middle-aged and predominantly healthy men and women into statin-popping patients, then one million of them will be back — just like my fiftysomething patient — in surgeries and consulting rooms, complaining of side-effects that, as well as muscle pain, include digestive problems, short-term memory loss, erectile dysfunction, sleep disorders, cataracts (mainly in women) and even type 2 diabetes."

No comments:

Post a Comment